Inventaire - your friends and communities are your best library

Medicines availability for non-communicable diseases: the case for standardized monitoring.

author

David Beran

published in: Globalization and Health

date of publication: 2015-05-07

Cites articles 11

Date

Title

Authors

2014-08-04

Estimating the prevalence and awareness rates of hypertension in Africa: a systematic analysis

Davies Adeloye
2014-05-01

Preparedness of Tanzanian health facilities for outpatient primary care of hypertension and diabetes: a cross-sectional survey

Richard J. Hayes, Heiner Grosskurth, Liam Smeeth, Saidi H Kapiga
2013-09-30

Monitoring service delivery for universal health coverage: the Service Availability and Readiness Assessment
2011-03-14

Differences in the availability of medicines for chronic and acute conditions in the public and private sectors of developing countries
2011-04-05

Priority actions for the non-communicable disease crisis

Robert Beaglehole, Richard Horton, George Allanmore Ogarren Alleyne, Perviz Asaria, Sally Casswell, Stephen Colagiuri, Andy Haines, Martin McKee, Bo Norrving, Peter Piot, Johanna Ralston, K Srinath Reddy, Franco Sassi, Nick Sheron, David Stuckler, Il Suh, Shah Ebrahim, Modi Mwatsama, Lancet NCD Action Group, Sania Nishtar
2010-06-09

Availability, price and affordability of cardiovascular medicines: a comparison across 36 countries using WHO/HAI data

Maaike S M van Mourik
2010-04-01

Measuring medicine prices in Peru: validation of key aspects of WHO/HAI survey methodology

Dennis Ross-Degnan, Jeanne Madden
2010-05-05

Looking beyond the issue of access to insulin: what is needed for proper diabetes care in resource poor settings
2008-11-29

Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis
2007-04

The availability and affordability of selected essential medicines for chronic diseases in six low- and middle-income countries

Oussama Khatib
2003-01-01

The selection and use of essential medicines. Report of the WHO Expert Committee, 2002 (including the 12th Model list of essential medicines)

Article - wd:Q35595254

Welcome to Inventaire

the library of your friends and communities

learn more